e-learning
resources
Milan 2017
Monday, 11.09.2017
New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Roles of periostin in patients with severe obstructive sleep apnea
H. Sunadome (Kyoto, Japan)
Source:
International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Session:
New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Session type:
Poster Discussion
Number:
2978
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Sunadome (Kyoto, Japan). Roles of periostin in patients with severe obstructive sleep apnea. 2978
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Vascular reactivity in patients with mild-moderate obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Airway inflammation in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002
Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Endothelial dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Chronic cough in patients with obstructive sleep apnea.
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Prevalence of thyroid disease in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept